老年转移性结直肠癌一线化疗FFCD 2001-02 III期研究的老年评估因素分析
FFCD 2001-02随机试验纳入282例75岁以上未经治疗的转移性结直肠癌患者,随机接受输注5-氟尿嘧啶为基础化疗,单药(FU)或联合伊立替康(IRI),其中123例完成基线老年评估。多因素分析显示无老年参数可预测客观缓解率或无进展生存期,工具性日常生活活动能力正常与更好的总生存期独立相关,双药化疗在部分亚组中对无进展生存期的获益存在差异。
要点
- 工具性日常生活活动能力正常是总生存期的独立预测因素。
- 无老年评估参数可预测客观缓解率或无进展生存期。
- 双药化疗在部分亚组中对无进展生存期的获益存在差异,需进一步探索。
核心结论
- 自主性评分(工具性日常生活活动能力)是总生存期的独立预测因素。
- 部分亚组中双药化疗疗效更好的趋势已被报告,应进一步探索。
研究设计与样本
- FFCD 2001-02随机III期试验,2003年6月至2010年5月入组282例75岁以上未经治疗的转移性结直肠癌患者。
- 患者随机接受输注5-氟尿嘧啶为基础化疗,单药(FU)或联合伊立替康(IRI)。
- 老年评估为可选程序,123例完成基线老年评估,其中FU组62例、IRI组61例。
主要发现
- 基线Charlson指数≤1者占75%,简易精神状态检查≤27/30者占31%,老年抑郁量表>2者占10%,工具性日常生活活动能力受损者占34%。
- 多因素分析显示无老年参数可预测客观缓解率或无进展生存期。
- 工具性日常生活活动能力正常与更好的总生存期独立相关;工具性日常生活活动能力正常患者有总生存期更好的趋势。
- 双药化疗对无进展生存期的获益在≤80岁、原发肿瘤未切除、白细胞>11,000 mm3和癌胚抗原>2N的患者亚组中存在差异。
局限性
- 老年评估为可选程序,282例入组患者中仅123例完成基线老年评估。
- 部分亚组中双药化疗疗效更好的趋势应进一步探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Several predictors of metastatic colorectal cancer (mCRC) outcomes have been described. Specific geriatric characteristics could be of interest to determine prognosis. METHOD: Elderly patients (75+) with previously untreated mCRC were randomly assigned to receive infusional 5-fluorouracil-based chemotherapy, either alone (FU) or in combination with irinotecan (IRI). Geriatric evaluations were included as an optional procedure. The predictive value of geriatric parameters was determined for the objective response rate (ORR), progression-free survival (PFS) and overall survival (OS). RESULTS: From June 2003 to May 2010, the FFCD 2001-02 randomised trial enrolled 282 patients. A baseline geriatric evaluation was done in 123 patients; 62 allocated to the FU arm and 61 to the IRI arm. The baseline Charlson index was ≤1 in 75%, Mini-Mental State Examination was ≤27/30 in 31%, Geriatric Depression Scale was >2 in 10% and Instrumental Activities of Daily Living (IADL) was impaired in 34% of the patients. Multivariate analyses revealed that no geriatric parameter was predictive for ORR or PFS. Normal IADL was independently associated with better OS. The benefit of doublet chemotherapy on PFS differed in subgroups of patients ≤80 years, with unresected primary tumour, leucocytes >11,000 mm3 and carcinoembryonic antigen >2N. There was a trend towards better OS in patients with normal IADL. CONCLUSION: The autonomy score was an independent predictor for OS. A trend toward a better efficacy of doublet chemotherapy in some subgroups of patients was reported and should be further explored.
引用
- Aparicio T, Gargot D, Teillet L, et al. Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients. Eur J Cancer. 2016. PMID: 27825697. doi:10.1016/j.ejca.2016.09.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。